Skip to content
Open Data Finder
Humanitarian Data Exchange

Covax Facility Interim Distribution Forecast

Published by HDX

About this dataset

This dataset contains a forecast on early availability of doses of the Pfizer-BioNTech vaccine and the AstraZeneca/Oxford vaccine to COVAX Facility participants. The forecast is as at 3 February 2021. This dataset contains figures on indicative distribution of 240 million doses of the AstraZeneca/Oxford vaccine, licensed to Serum Institute of India (SII) and 96 million doses of the AstraZeneca/Oxford vaccine, under the advance purchase agreement between Gavi, the Vaccine Alliance and AstraZeneca for Q1 & Q2 2021. It also contains an overview of exceptional first round allocation of 1.2 million doses of the WHO Emergency Use Listing (EUL)-approved Pfizer-BioNTech vaccine for Q1 2021. The data was manually extracted from the The COVAX Facility Interim Distribution Forecast which was announced by COVAX on 3 February 2021.

Covax Facility Interim Distribution Forecast · Open Data Finder